Next Article in Journal
Emulsifying Activity and Stability of a Non-Toxic Bioemulsifier Synthesized by Microbacterium sp. MC3B-10
Next Article in Special Issue
BTG1 Expression Correlates with the Pathogenesis and Progression of Ovarian Carcinomas
Previous Article in Journal
Potential of the Angiotensin Receptor Blockers (ARBs) Telmisartan, Irbesartan, and Candesartan for Inhibiting the HMGB1/RAGE Axis in Prevention and Acute Treatment of Stroke
Previous Article in Special Issue
Exploring the Glycosylation of Serum CA125
Review

The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients

1
Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, 1720 East 120th Street, Los Angeles, CA 90059, USA
2
Laboratory Diagnostic Medicine, Faculty of Pharmacy, Mazzeh (17th April Street), Damascus University, Damascus, Syria
3
David Geffen School of Medicine at UCLA, UCLA's Jonsson Comprehensive Cancer Center, 8-684 Factor Building, Box 951781, Los Angeles, CA 90095-1781, USA
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2013, 14(9), 18925-18958; https://doi.org/10.3390/ijms140918925
Received: 4 June 2013 / Revised: 26 August 2013 / Accepted: 30 August 2013 / Published: 13 September 2013
(This article belongs to the Special Issue Advances in Cancer Diagnosis)
Qualitative and quantitative testing of circulating cell free DNA (CCFDNA) can be applied for the management of malignant and benign neoplasms. Detecting circulating DNA in cancer patients may help develop a DNA profile for early stage diagnosis in malignancies. The technical issues of obtaining, using, and analyzing CCFDNA from blood will be discussed. View Full-Text
Keywords: circulating cell free DNA; neoplasms; early diagnosis; follow up on cancer treatment; prognosis circulating cell free DNA; neoplasms; early diagnosis; follow up on cancer treatment; prognosis
MDPI and ACS Style

Elshimali, Y.I.; Khaddour, H.; Sarkissyan, M.; Wu, Y.; Vadgama, J.V. The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients. Int. J. Mol. Sci. 2013, 14, 18925-18958. https://doi.org/10.3390/ijms140918925

AMA Style

Elshimali YI, Khaddour H, Sarkissyan M, Wu Y, Vadgama JV. The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients. International Journal of Molecular Sciences. 2013; 14(9):18925-18958. https://doi.org/10.3390/ijms140918925

Chicago/Turabian Style

Elshimali, Yahya I., Husseina Khaddour, Marianna Sarkissyan, Yanyuan Wu, and Jaydutt V. Vadgama 2013. "The Clinical Utilization of Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients" International Journal of Molecular Sciences 14, no. 9: 18925-18958. https://doi.org/10.3390/ijms140918925

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop